← Back to Patent Explorer
US5480776A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for prediction of premature labor

Assignee: Cytyc Corp
•
Filing: 1994-05-12
•
Granted: 1996-01-02
•
Expires: 2014-05-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for detecting the onset of labor in a patient, which comprises analyzing a body fluid of the patient for estriol concentration; correlating the concentration with a standard value; and relating a higher concentration of estriol relative to the standard value as an indication of potential onset of pre-term labor. The standard is usually selected from the group consisting of (1) a predetermined range of estriol concentrations for the body fluid in normal pregnant humans at a preselected time relative to normal, full-term delivery, or (2) a previously measured estriol concentration of the same body fluid of the same pregnant human. Use of this method does not require determination of an estriol/progesterone concentration ratio in the body fluid being test.

Inventors

  • 👤 Vivian K. Dullien

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 17:58
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/743; Y; Y10; Y10T; Y10T436/00; Y10T436/20; Y10T436/203332

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 165 words
A method of screening for the potential onset of preterm labor in a pregnant human at 36 weeks gestation or earlier, which comprises: (a) analyzing a sample body fluid from said pregnant human to determine unconjugated estriol concentration in the body fluid; (b) correlating said concentration determined in step (a) with (1) a predetermined standard unconjugated estriol concentration for said body fluid, or (2) a previously measured unconjugated estriol concentration in said body fluid of said pregnant human to determine a rate of increase in unconjugated estriol concentration in the body fluid of said pregnant human; and (c) relating a higher concentration of unconjugated estriol in the body fluid of said pregnant human relative to said predetermined standard unconjugated estriol concentration, or relating an elevated rate of increase in unconjugated estriol concentration in the body fluid of said pregnant human as an indication of potential onset of pro-term labor in said pregnant human, wherein said relating does not consider progesterone concentration in said body fluid.
Claim 2
Independent Claim 165 words
A method of screening for the potential onset of preterm labor in a pregnant human at 36 weeks gestation or earlier, which comprises: (a) analyzing a sample body fluid from said pregnant human to determine unconjugated estriol concentration in the body fluid; (b) correlating said concentration determined in step (a) with (1) a predetermined standard unconjugated estriol concentration for said body fluid, or (2) a previously measured unconjugated estriol concentration in said body fluid of said pregnant human to determine a rate of increase in unconjugated estriol concentration in the body fluid of said pregnant human; and (c) relating a higher concentration of unconjugated estriol in the body fluid of said pregnant human relative to said predetermined standard unconjugated estriol concentration, or relating an elevated rate of increase in unconjugated estriol concentration in the body fluid of said pregnant human as an indication of potential onset of pro-term labor in said pregnant human, wherein said relating does not consider progesterone concentration in said body fluid.
Claim 3
Dependent Claim 20 words
The method of claim 1, wherein said body fluid is saliva, plasma, serum, urine, cervical secretion, vaginal secretion, or sweat.
Claim 4
Dependent Claim 23 words
The method of claim 2, wherein said body fluid is saliva and said predetermined standard unconjugated estriol concentration is at least 5 nM.
Claim 5
Dependent Claim 23 words
The method of claim 2, wherein said body fluid is saliva and said predetermined standard unconjugated estriol concentration is at least 7 nM.
Claim 6
Dependent Claim 52 words
The method of claim 1, wherein said concentration determined in step (a) is determined at 30 weeks gestation or earlier and said predetermined standard unconjugated estriol concentration is at least as high as the 95th percentile concentration of unconjugated estriol for said body fluid for a normal pregnancy at 40 weeks gestation.
Claim 7
Dependent Claim 79 words
The method of claim 1, wherein said concentration determined in step (a) is determined within one week of the previously measured unconjugated estriol concentration in said body fluid of said pregnant human, and wherein an elevated rate of increase in unconjugated estriol concentration in the body fluid of said pregnant human is indicated when said concentration determined in step (a) exceeds the previously measured unconjugated estriol concentration in said body fluid of said pregnant human by at least 50%.
Claim 8
Dependent Claim 16 words
The method of claim 1, wherein said analyzing comprises a non-instrumented enzyme immunoassay for unconjugated estriol.
Claim 9
Dependent Claim 22 words
The method of claim 7, wherein said assay produces a color change at a concentration above said predetermined standard unconjugated estriol concentration.
Claim 10
Independent Claim 150 words
A method of screening for the potential onset of preterm labor in a pregnant human at 36 weeks gestation or earlier, which comprises: (a) analyzing a saliva sample from said pregnant human to determine the estriol concentration in said saliva sample; (b) correlating said concentration determined in step (a) with (1) a predetermined standard estriol concentration for saliva, or (2) a previously measured estriol concentration in saliva of said pregnant human to determine a rate of increase in estriol concentration in saliva of said pregnant human; and (c) relating a higher concentration of estriol in the saliva sample of said pregnant human relative to said predetermined standard estriol concentration, or relating an elevated rate of increase in estriol concentration in the saliva of said pregnant human, as an indication of potential onset of pre-term labor in said pregnant human, wherein said relating does not consider progesterone concentration in said saliva.
Claim 11
Independent Claim 150 words
A method of screening for the potential onset of preterm labor in a pregnant human at 36 weeks gestation or earlier, which comprises: (a) analyzing a saliva sample from said pregnant human to determine the estriol concentration in said saliva sample; (b) correlating said concentration determined in step (a) with (1) a predetermined standard estriol concentration for saliva, or (2) a previously measured estriol concentration in saliva of said pregnant human to determine a rate of increase in estriol concentration in saliva of said pregnant human; and (c) relating a higher concentration of estriol in the saliva sample of said pregnant human relative to said predetermined standard estriol concentration, or relating an elevated rate of increase in estriol concentration in the saliva of said pregnant human, as an indication of potential onset of pre-term labor in said pregnant human, wherein said relating does not consider progesterone concentration in said saliva.

References Cited (Backward Citations)

US4454232A Cited
US5028535A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-01-01 1999-07-03 2000-01-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-01-01 2003-07-03 2004-01-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-01-01 2007-07-03 2008-01-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag